Search

Your search keyword '"Bouchara JP"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Bouchara JP" Remove constraint Author: "Bouchara JP"
227 results on '"Bouchara JP"'

Search Results

1. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

2. Scedosporium and Lomentospora: an updated overview of underrated opportunists

3. Flore fongique des bacs à sable mise en evidence signification

5. Detection of Specific IgE against Molds Involved in Allergic Bronchopulmonary Mycoses in Patients with Cystic Fibrosis.

6. The epidemiology of invasive fungal infections in transplant recipients.

8. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues.

9. Fungal Colonization of the Airways of Patients with Cystic Fibrosis: the Role of the Environmental Reservoirs.

10. Functional insights into human macrophage response against Scedosporium apiospermum and Scedosporium dehoogii.

11. Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System.

12. Outcome of patients with cystic fibrosis colonized by Scedosporium and Lomentospora species: A longitudinal cohort study.

13. Microbiota and fungal-bacterial interactions in the cystic fibrosis lung.

14. Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.

15. Lignin-Modifying Enzymes in Scedosporium Species.

16. The high osmolarity glycerol (HOG) pathway in fungi † .

17. Trends in the epidemiology of dermatophytosis in the Middle East and North Africa region.

18. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.

19. Oxidative stress response pathways in fungi.

20. Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients.

21. Highly Conserved gsc1 Gene of Pneumocystis jirovecii in Patients with or without Prior Exposure to Echinocandins.

22. An Optimized Electroporation Procedure for Genetic Transformation of Candida auris.

23. Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen Scedosporium aurantiacum .

24. Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans .

25. Draft Genome Sequence of the Environmental Fungus Scedosporium dehoogii.

27. Selection of Pneumocystis jirovecii Inosine 5'-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid.

28. Emerging Fungal Threats in Cystic Fibrosis.

30. Biochemical and structural studies of target lectin SapL1 from the emerging opportunistic microfungus Scedosporium apiospermum.

31. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.

32. The Glycosylphosphatidylinositol-Anchored Superoxide Dismutase of Scedosporium apiospermum Protects the Conidia from Oxidative Stress.

33. Lower Funneling Pathways in Scedosporium Species.

34. Characterisation of the antifungal effects of a plant-based compound, CIN-102, on the main septal filamentous fungi involved in human pathology.

35. Mycopathologia 2020: Legacy and Change to Remain Relevant for Content, Creation, and Communication.

36. Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon.

38. Tinea capitis at the University Hospital of Tizi-Ouzou, Algeria, and first isolation of Trichophyton tonsurans.

39. ELISA Test for the Serological Detection of Scedosporium / Lomentospora in Cystic Fibrosis Patients.

40. Comparative transcriptome analysis unveils the adaptative mechanisms of Scedosporium apiospermum to the microenvironment encountered in the lungs of patients with cystic fibrosis.

41. Synthesis of the Hydroxamate Siderophore N α -Methylcoprogen B in Scedosporium apiospermum Is Mediated by sidD Ortholog and Is Required for Virulence.

42. Application of Fusarium sp. immobilized on multi-walled carbon nanotubes for solid-phase extraction and trace analysis of heavy metal cations.

43. Antifungal susceptibility testing practices in mycology laboratories in France, 2018.

44. Advances in understanding and managing Scedosporium respiratory infections in patients with cystic fibrosis.

45. Scedosporium species in soils from various biomes in Northwestern Morocco.

46. Pneumocystis jirovecii Diversity in Réunion, an Overseas French Island in Indian Ocean.

47. Biotinylated Oligo-α-(1 → 4)-d-galactosamines and Their N-Acetylated Derivatives: α-Stereoselective Synthesis and Immunology Application.

48. Potential of Chemically Synthesized Oligosaccharides To Define the Carbohydrate Moieties of the Fungal Cell Wall Responsible for the Human Immune Response, Using Aspergillus fumigatus Galactomannan as a Model.

49. Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region.

50. Scedosporium apiospermum.

Catalog

Books, media, physical & digital resources